针对ADAPT-TDM的研究协议:一种β-乳糖抗生素剂量适应可行性随机对照试验使用治疗药物监测
Rekha Pai Mangalore1,2, Ming Gene Chai3,4, Jeffrey Pope5
1Infectious Disease, Alfred Health, Melbourne, Victoria, Australia rekhapai16@yahoo.co.in.
BMJ open
|July 1, 2024
概括
这项研究评估了使用治疗药物监测 (TDM) 来指导危急病患者的β-乳糖抗生素剂量的可行性. 它旨在改善抗生素暴露,减少治疗失败或毒性.
科学领域:
- 药理动力学和药理动力学
- 关键护理医学 关键护理医学
- 抗生素管理的管理.
背景情况:
- 危急病患者通常因改变了影响药物药理动学的生理学而接受低于最佳的β-乳糖抗生素剂量.
- 低于最佳的抗生素度增加了治疗失败和毒性的风险.
- 治疗药物监测 (TDM) 可以个性化剂量以优化抗生素暴露,但其在重症监护病房 (ICU) 的实施尚未建立.
研究的目的:
- 评估在重症监护室 (ICU) 环境中对重症患者实施β-乳糖TDM导向剂量的可行性和可靠性.
- 评估TDM在改善抗生素暴露和患者结果方面的潜力.
- 为了收集数据进行更大规模的Beta-lactam TDMIII期试验.
主要方法:
- 一个单中心的,未盲目的,可行性随机对照试验 (ADAPT-TDM) 涉及多达60名重症成人参与者.
- 干预组每天接受TDM和对beta-lactam抗生素的剂量调整.
- 对照组接受了血采样的标准护理,但没有进行剂量调整.
主要成果:
- 主要结果集中在招聘的可行性和TDM流程的忠实性 (样本采集,处理,结果可用性).
- 二级结局包括达到目标抗生素度,采用TDM导向剂量,以及神经毒性,肝毒性和毒性等不良事件的发生率.
- 这项研究旨在确定β-乳糖TDM导向剂量调整是否可重复和可行.
结论:
- ADAPT-TDM试验将提供关于在ICU中实施β-乳糖TDM的可行性和可重复性的关键数据.
- 研究结果将为未来的III期试验的设计和执行提供信息,以优化重症患者的抗生素治疗.
- 成功实施TDM可以通过确保足够的抗生素暴露来改善患者的治疗结果.
更多相关视频
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
1.8K
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
9.8K
相关概念视频
Rational Dosage Regimen: Maintenance Dose and Loading Dose
4.0K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.0K
Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
Pulmonary Tuberculosis V
177
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
177
Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Renal Failure: Dose Adjustments
79
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
79
